ClinicalTrials.Veeva

Menu

Effect of Dairy Protein Yogourt vs Plant-based Yogourt on Body Weight, Body Composition, Bone Health and Gut Microbiota (PROYO)

L

Laval University

Status

Enrolling

Conditions

Bone Health
Body Weight Change
Bone Metabolism
Gut Microbiota
Metabolic Health
Body Composition Changes

Treatments

Dietary Supplement: Dairy yogurt
Dietary Supplement: Plant based yogurt
Dietary Supplement: No yogurt

Study type

Interventional

Funder types

Other

Identifiers

NCT07578103
PROYO 2022-108

Details and patient eligibility

About

The consumption of an adequate quantity of protein in the diet is essential to maintain a healthy body composition and functioning. It is also well established that all proteins are not equal regarding their ability to promote health benefits. Recently, we have innovated in that matter by showing that under the context of high intake of dietary fat, the dairy protein casein was more effective than a mix of proteins representative of a western diet to prevent body weight gain and insulin resistance. This was explained in part by modifications of the gut microbiota. This finding represents the main conceptual basis of the present research program that is aimed to determine the impact of dairy protein from yogurt compared to a plant-based equivalent on body composition indicators including muscle mass and bone mineral density, in relation to the profile of the gut microbiota, the production of newly discovered protein-derived metabolites, and markers of metabolic health. This program will include a human and an animal component requiring the testing of these variables before and after a standardized intervention. The human component will be a clinical study consisting of a 12-week diet-based weight loss intervention in postmenopausal overweight women being randomly assigned to one of the three following groups: yogurt, plant-based yogurt, or kept on diet without supplements. The animal experimentation will permit to causally determine the implication of the gut microbiota in the protein effects following transfer of the human bacteria to germ free mice and validate the benefits seen in humans. It is anticipated that these two complementary investigative approaches will allow a thorough documentation of the impact of fermented dairy protein on body composition and functioning, a better understanding of the underlying mechanisms, and the identification of new biomarkers to better appreciate related health benefits.

Enrollment

75 estimated patients

Sex

Female

Ages

40+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Postmenopausal women (absence of menstruation for at least 1 year and FSH > 40 IU/L)
  • BMI between 27.0 and 39.9 kg/m²
  • Sedentary or moderately active

Exclusion criteria

  • Body weight change greater than 5 kg in the 3 months preceding the study
  • Currently dieting or following specific dietary patterns
  • Previous or planned bariatric surgery
  • Food allergies or intolerances (particularly dairy proteins and lactose)
  • Serious or problematic health conditions (e.g., renal insufficiency, diabetes, Cushing's disease, Paget's disease, parathyroid disorders, inflammatory bowel disease, uncontrolled thyroid disease, etc.)
  • Fracture within the past year
  • Hormone therapy
  • Medications affecting bone metabolism (e.g., osteoporosis treatments, anti-estrogen therapy for breast cancer, epilepsy treatments)
  • Antibiotic use within the 6 months preceding the study
  • Use of probiotic supplements (capsules)
  • More than two alcoholic drinks per day
  • Smoking
  • Drug abuse

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

75 participants in 3 patient groups, including a placebo group

Dairy yogurt
Experimental group
Treatment:
Dietary Supplement: Dairy yogurt
Plant-based yogurt
Active Comparator group
Treatment:
Dietary Supplement: Plant based yogurt
No yogurt
Placebo Comparator group
Treatment:
Dietary Supplement: No yogurt

Trial contacts and locations

1

Loading...

Central trial contact

Julie Marois, M.Sc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems